Vincent Lacroix

Vincent Lacroix

Auto-generated profile, based on publicly available information

Vincent Lacroix

Laboratoire de Biométrie et Biologie Evolutive (LBBE, UMR 5558), CNRS, BAOBAB, Université Lyon 1, Villeurbanne, France

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2012 in Genome Research
Verified
Journal Article
Open access
PDF file
Milana Frenkel-MorgensternMilana Frenkel-Morgenstern
Milana Frenkel-Morgenstern
VLVincent Lacroix
Vincent Lacroix
IEIakes Ezkurdia
Iakes Ezkurdia
YLYishai Levin
Yishai Levin
AGAlexandra Gabashvili
Alexandra Gabashvili
AVAlfonso Valencia
Alfonso Valencia
Chimeric RNAs comprise exons from two or more different genes and have the potential to encode novel proteins that alter cellular phenotypes. To date, numerous putative chimeric transcripts have been identified among the ESTs isolated from several organisms and using high throughput RNA sequencing. The few corresponding protein products that have been characterized mostly result from chromosomal translocations and are associated with cancer. Here, we systematically establish that some of the putative chimeric transcripts are genuinely expressed in human cells. Using high throughput RNA sequencing, mass spectrometry experimental data, and functional annotation, we studied 7424 putative human chimeric RNAs. We confirmed the expression of 175 chimeric RNAs in 16 human tissues, with an abundance varying from 0.06 to 17 RPKM (Reads Per Kilobase per Million mapped reads). We show that these chimeric RNAs are significantly more tissue-specific than non-chimeric transcripts. Moreover, we present evidence that chimeras tend to incorporate highly expressed genes. Despite the low expression level of most chimeric RNAs, we show that 12 novel chimeras are translated into proteins detectable in multiple shotgun mass spectrometry experiments. Furthermore, we confirm the expression of three novel chimeric proteins using targeted mass spectrometry. Finally, based on our functional annotation of exon organization and preserved domains, we discuss the potential features of chimeric proteins with illustrative examples and suggest that chimeras significantly exploit signal peptides and transmembrane domains, which can alter the cellular localization of cognate proteins. Taken together, these findings establish that some chimeric RNAs are translated into potentially functional proteins in humans.

19 April 2012 in BMC Bioinformatics
Verified
Journal Article
Open access
GSGustavo At Sacomoto
Gustavo At Sacomoto
JKJanice Kielbassa
Janice Kielbassa
RCRayan Chikhi
Rayan Chikhi
RURaluca Uricaru
Raluca Uricaru
PAPavlos Antoniou
Pavlos Antoniou
VLVincent Lacroix
Vincent Lacroix
Background: In this paper, we address the problem of identifying and quantifying polymorphisms in RNA-seq data when no reference genome is available, without assembling the full transcripts. Based on the fundamental idea that each polymorphism corresponds to a recognisable pattern in a De Bruijn graph constructed from the RNA-seq reads, we propose a general model for all polymorphisms in such graphs. We then introduce an exact algorithm, called KIS SPLICE, to extract alternative splicing events. Results: We show that KIS SPLICE enables to identify more correct events than general purpose transcriptome assemblers. Additionally, on a 71 M reads dataset from human brain and liver tissues, KIS SPLICE identified 3497 alternative splicing events, out of which 56% are not present in the annotations, which confirms recent estimates showing that the complexity of alternative splicing has been largely underestimated so far. Conclusions: We propose new models and algorithms for the detection of polymorphism in RNA-seq data. This opens the way to a new kind of studies on large HTS RNA-seq datasets, where the focus is not the global reconstruction of full-length transcripts, but local assembly of polymorphic regions. KIS SPLICE is available for download at http://alcovna.genouest.org/kissplice/.

25 July 2016 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
HLHélène Lopez-Maestre
Hélène Lopez-Maestre
LBLilia Brinza
Lilia Brinza
CMCamille Marchet
Camille Marchet
JKJanice Kielbassa
Janice Kielbassa
SBSylvère Bastien
Sylvère Bastien
VLVincent Lacroix
Vincent Lacroix
SNPs (Single Nucleotide Polymorphisms) are genetic markers whose precise identification is a prerequisite for association studies. Methods to identify them are currently well developed for model species, but rely on the availability of a (good) reference genome, and therefore cannot be applied to non-model species. They are also mostly tailored for whole genome (re-)sequencing experiments, whereas in many cases, transcriptome sequencing can be used as a cheaper alternative which already enables to identify SNPs located in transcribed regions. In this paper, we propose a method that identifies, quantifies and annotates SNPs without any reference genome, using RNA-seq data only. Individuals can be pooled prior to sequencing, if not enough material is available from one individual. Using pooled human RNA-seq data, we clarify the precision and recall of our method and discuss them with respect to other methods which use a reference genome or an assembled transcriptome. We then validate experimentally the predictions of our method using RNA-seq data from two non-model species. The method can be used for any species to annotate SNPs and predict their impact on the protein sequence. We further enable to test for the association of the identified SNPs with a phenotype of interest.

9 March 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CBClara Benoit-Pilven
Clara Benoit-Pilven
CMCamille Marchet
Camille Marchet
ECEmilie Chautard
Emilie Chautard
LLLeandro Lima
Leandro Lima
MLMarie-Pierre Lambert
Marie-Pierre Lambert
VLVincent Lacroix
Vincent Lacroix
Genome-wide analyses estimate that more than 90% of multi exonic human genes produce at least two transcripts through alternative splicing (AS). Various bioinformatics methods are available to analyze AS from RNAseq data. Most methods start by mapping the reads to an annotated reference genome, but some start by a de novo assembly of the reads. In this paper, we present a systematic comparison of a mapping-first approach (FaRLine) and an assembly-first approach (KisSplice). We applied these methods to two independent RNAseq datasets and found that the predictions of the two pipelines overlapped (70% of exon skipping events were common), but with noticeable differences. The assembly-first approach allowed to find more novel variants, including novel unannotated exons and splice sites. It also predicted AS in recently duplicated genes. The mapping-first approach allowed to find more lowly expressed splicing variants, and splice variants overlapping repeats. This work demonstrates that annotating AS with a single approach leads to missing out a large number of candidates, many of which are differentially regulated across conditions and can be validated experimentally. We therefore advocate for the combined use of both mapping-first and assembly-first approaches for the annotation and differential analysis of AS from RNAseq datasets.

7 June 2019 in RNA
Verified
Journal Article
Open access
PDF file
ACAudric Cologne
Audric Cologne
CBClara Benoit-Pilven
Clara Benoit-Pilven
ABAlicia Besson
Alicia Besson
APAudrey Putoux
Audrey Putoux
ACAmandine Campan-Fournier
Amandine Campan-Fournier
VLVincent Lacroix
Vincent Lacroix
Minor intron splicing plays a central role in human embryonic development and survival. Indeed, biallelic mutations in RNU4ATAC, transcribed into the minor spliceosomal U4atac snRNA, are responsible for three rare autosomal recessive multimalformation disorders named Taybi–Linder (TALS/MOPD1), Roifman (RFMN), and Lowry–Wood (LWS) syndromes, which associate numerous overlapping signs of varying severity. Although RNA-seq experiments have been conducted on a few RFMN patient cells, none have been performed in TALS, and more generally no in-depth transcriptomic analysis of the ∼700 human genes containing a minor (U12-type) intron had been published as yet. We thus sequenced RNA from cells derived from five skin, three amniotic fluid, and one blood biosamples obtained from seven unrelated TALS cases and from age- and sex-matched controls. This allowed us to describe for the first time the mRNA expression and splicing profile of genes containing U12-type introns, in the context of a functional minor spliceosome. Concerning RNU4ATAC-mutated patients, we show that as expected, they display distinct U12-type intron splicing profiles compared to controls, but that rather unexpectedly mRNA expression levels are mostly unchanged. Furthermore, although U12-type intron missplicing concerns most of the expressed U12 genes, the level of U12-type intron retention is surprisingly low in fibroblasts and amniocytes, and much more pronounced in blood cells. Interestingly, we found several occurrences of introns that can be spliced using either U2, U12, or a combination of both types of splice site consensus sequences, with a shift towards splicing using preferentially U2 sites in TALS patients’ cells compared to controls.

10 June 2011 in BMC Genomics
Verified
Journal Article
Open access
PDF file
AVAmélie S Véron
Amélie S Véron
CLClaire Lemaitre
Claire Lemaitre
CGChristian Gautier
Christian Gautier
VLVincent Lacroix
Vincent Lacroix
MSMarie-France Sagot
Marie-France Sagot
Folding and intermingling of chromosomes has the potential of bringing close to each other loci that are very distant genomically or even on different chromosomes. On the other hand, genomic rearrangements also play a major role in the reorganisation of loci proximities. Whether the same loci are involved in both mechanisms has been studied in the case of somatic rearrangements, but never from an evolutionary standpoint.